Page last updated: 2024-09-02

idarubicinol and Lymphoma, Non-Hodgkin

idarubicinol has been researched along with Lymphoma, Non-Hodgkin in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aita, P; Basso, B; Boiocchi, M; Corona, G; Ruolo, G; Rupolo, M; Sorio, R; Toffoli, G	1
Braess, J; Hiddemann, W; Kaufmann, CC; Kern, W; Kühn, S; Rührs, H; Schleyer, E; Sträubel, G; Unterhalt, M	2
Baltes-Engler, S; Dederichs, B; Diehl, V; Engelhard, M; Engert, A; Küpper, F; Lathan, B; Reiser, M; Scheulen, ME; Schnell, R; Tesch, H; Wilhelm, M; Winterhalter, B; Wörmann, B	1
Cocorocchio, E; Corsini, C; D'Incalci, M; Ferrucci, PF; Ghielmini, M; Mancuso, P; Martinelli, G; Mezzetti, M; Mori, A; Paolucci, M; Riggi, M; Tealdo, F; Zucchetti, M	1

Trials

2 trial(s) available for idarubicinol and Lymphoma, Non-Hodgkin

Article	Year
Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curve. Leukemia, 1996, Volume: 10, Issue:4 Topics: Acute Disease; Administration, Oral; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Idarubicin; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Middle Aged	1996
A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphoma. Leukemia & lymphoma, 1997, Volume: 24, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Individuality; Lymphoma, Non-Hodgkin; Male; Middle Aged	1997

Article

Year

Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curve.

Leukemia, 1996, Volume: 10, Issue:4

Topics: Acute Disease; Administration, Oral; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Idarubicin; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Middle Aged

1996

A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphoma.

Leukemia & lymphoma, 1997, Volume: 24, Issue:5-6

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Individuality; Lymphoma, Non-Hodgkin; Male; Middle Aged

1997

Other Studies

3 other study(ies) available for idarubicinol and Lymphoma, Non-Hodgkin

Article	Year
Pharmacokinetic comparison of 120-hour infusion versus hyperfractionated oral administration of idarubicin. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Area Under Curve; Daunorubicin; Female; Humans; Idarubicin; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged	2004
Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curve. Leukemia, 1997, Volume: 11 Suppl 5 Topics: Administration, Oral; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Chromatography, High Pressure Liquid; Daunorubicin; Half-Life; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Middle Aged; Regression Analysis	1997
Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin. British journal of cancer, 2000, Volume: 82, Issue:3 Topics: Adult; Antineoplastic Agents; Daunorubicin; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Treatment Outcome	2000